Risk Factors Analysis for the Development of Hypocomplementemia in Rheumatoid Arthritis Patients: A Single-Center Retrospective Study

References

• Arias de la Rosa I, Escudero-Contreras A, Ruiz-Ponce M, et al. Molecular changes in the adipose tissue induced by rheumatoid arthritis: effects of disease-modifying anti-rheumatic drugs. Front Immunol. 2021;12:744022. doi:10.3389/fimmu.2021.744022
   PubMed Web of Science ®Google Scholar
• Conforti A, Di Cola I, Pavlych V, et al. Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev. 2021;20(2):102735. doi:10.1016/j.autrev.2020.102735
   PubMed Web of Science ®Google Scholar
• Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021;10(11):2857. doi:10.3390/cells10112857
   PubMed Web of Science ®Google Scholar
• Holers VM, Banda NK. Complement in the initiation and evolution of rheumatoid arthritis. Front Immunol. 2018;9:1057. doi:10.3389/fimmu.2018.01057
   PubMed Web of Science ®Google Scholar
• Nass FR, Skare TL, Goeldner I, Nisihara R, Messias-Reason IJ, Utiyama SR. Association of complement factor B allotypes and serum biomarkers in rheumatoid arthritis patients and their relatives. Int J Immunogenet. 2015;42(6):439–444. doi:10.1111/iji.12232
   PubMed Web of Science ®Google Scholar
• Fukami Y, Koike H, Iijima M, Mouri N, Nishi R, Katsuno M. Role of complement components in vasculitic neuropathy associated with systemic lupus erythematosus and rheumatoid arthritis. Muscle Nerve. 2022;66(2):175–182. doi:10.1002/mus.27636
   PubMed Web of Science ®Google Scholar
• Bemis EA, Norris JM, Seifert J, et al. Complement and its environmental determinants in the progression of human rheumatoid arthritis. Mol Immunol. 2019;112:256–265. doi:10.1016/j.molimm.2019.05.012
   PubMed Web of Science ®Google Scholar
• Triggianese P, Conigliaro P, De Martino E, Monosi B, Chimenti MS. Overview on the link between the complement system and auto-immune articular and pulmonary disease. Open Access Rheumatol. 2023;15:65–79. doi:10.2147/OARRR.S318826
   PubMed Web of Science ®Google Scholar
• Ricklin D, Reis ES, Mastellos DC, Gros P, Lambris JD. Complement component C3 - The “Swiss Army Knife” of innate immunity and host defense. Immunol Rev. 2016;274(1):33–58. doi:10.1111/imr.12500
   PubMed Web of Science ®Google Scholar
• Jordán-González P, Gago-Piñero R, Varela-Rosario N, Pérez-Ríos N, Vilá LM. Characterization of a subset of patients with primary Sjögren’s syndrome initially presenting with C3 or C4 hypocomplementemia. Eur J Rheumatol. 2020;7(3):112–117. doi:10.5152/eurjrheum.2020.19132
   PubMed Web of Science ®Google Scholar
• Franco AE, Schur PH. Hypocomplementemia in rheumatoid arthritis. Arthritis Rheum. 1971;14(2):231–238. doi:10.1002/art.1780140206
   PubMedGoogle Scholar
• Hunder GG, McDuffie FC. Hypocomplementemia in rheumatoid arthritis. Am J Med. 1973;54(4):461–472. doi:10.1016/0002-9343(73)90042-9
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
   PubMed Web of Science ®Google Scholar
• Ballanti E, Perricone C, Di Muzio G, et al. Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors. Autoimmun Rev. 2011;10(10):617–623. doi:10.1016/j.autrev.2011.04.012
   PubMed Web of Science ®Google Scholar
• Bieber A, Markovits D, Toledano K, et al. Hypocomplementemia during tocilizumab treatment: long-term follow-up results. Medicine. 2022;101(24):e29528. doi:10.1097/MD.0000000000029528
   PubMed Web of Science ®Google Scholar
• Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun. 2010;34(3):J276–86. doi:10.1016/j.jaut.2009.11.014
   PubMed Web of Science ®Google Scholar
• Saraux A, Bourdon V, Devauchelle V, Le Goff P. Is hypocomplementemia useful for diagnosing or predicting extra-articular manifestations in patients with rheumatoid arthritis? Joint Bone Spine. 2001;68(6):487–492. doi:10.1016/S1297-319X(01)00312-8
   PubMed Web of Science ®Google Scholar
• Rönnelid J, Turesson C, Kastbom A. Autoantibodies in rheumatoid arthritis - laboratory and clinical perspectives. Front Immunol. 2021;12:685312. doi:10.3389/fimmu.2021.685312
   PubMed Web of Science ®Google Scholar
• Liu X, Jia R, Zhao J, Li Z. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. J Rheumatol. 2009;36(6):1136–1142. doi:10.3899/jrheum.080796
   PubMed Web of Science ®Google Scholar
• Lin W, Xin Z, Wang J, et al. Hypocomplementemia in primary Sjogren’s syndrome: association with serological, clinical features, and outcome. Clin Rheumatol. 2022;41(7):2091–2102. doi:10.1007/s10067-022-06135-w
   PubMed Web of Science ®Google Scholar
• Barczyńska TA, Dura M, Blumfield E, et al. DAS28 score vs. ultrasound examination for assessment of rheumatoid arthritis disease activity: comparison and discussion of pros and cons. Reumatologia. 2015;53(4):213–218. doi:10.5114/reum.2015.53999
   PubMedGoogle Scholar
• van Riel PL, Renskers L. The Disease Activity Score (DAS) and the disease activity score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(5 Suppl 101):S40–s4.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu J, Xin L, et al. Factors influencing the Sharp score of 1057 patients with rheumatoid arthritis and anemia: a retrospective study. J Int Med Res. 2022;50(3):3000605221088560. doi:10.1177/03000605221088560
   Web of Science ®Google Scholar
• Möller B, Everts-Graber J, Florentinus S, Li Y, Kupper H, Finckh A. Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: secondary Analysis From a Phase III Trial. Arthritis Care Res. 2018;70(6):861–868. doi:10.1002/acr.23427
   Web of Science ®Google Scholar
• Zhou M, Yuan F. Hypocomplementemia in primary sjogren’s syndrome: a retrospective study of 120 treatment-naive Chinese patients. Int J Gen Med. 2022;15:359–366. doi:10.2147/IJGM.S346188
   PubMed Web of Science ®Google Scholar